Prescription drug · ANDA
Succinylcholine Chloride NDC 43066-129
Succinylcholine chloride dihydrate 20 mg/mL · Injection, Solution · Intramuscular, Intravenous · Baxter Healthcare Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43066-129-05 | 4306601290543066012905 | 5 CARTON in 1 CARTON (43066-129-05) / 1 SYRINGE, PLASTIC in 1 CARTON (43066-129-01) / 10 mL in 1 SYRINGE, PLASTICMarketed from Sep 24, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Succinylcholine Chloride
- Generic name (nonproprietary)
- succinylcholine chloride
- Active ingredients
- Succinylcholine chloride dihydrate — 20 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Baxter Healthcare CorporationNDC labeler code 43066
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218878
- Marketing start
- Listing expires
- Other FDA classes
- Neuromuscular Depolarizing Blockade (Physiologic effect)
- Identifiers
- Product ID 43066-129_3b9ee5c1-e92b-4ebe-98d2-d3d6ffe3dd1cSPL ID 3b9ee5c1-e92b-4ebe-98d2-d3d6ffe3dd1cSPL set ID 30f58922-3c74-4813-ace0-fcd2024acd09RxCUI 2598128, 2694114UNII 8L0S1G435E
- Pharmacologic class
- Depolarizing Neuromuscular Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N443066012905followed by a unit qualifier and the quantityPackage 43066-0129-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
About NDC 43066-129
- What is NDC 43066-129?
- 43066-129 is the product NDC for Succinylcholine Chloride, Succinylcholine chloride dihydrate 20 mg/mL injection, solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Succinylcholine Chloride.
- What is the active ingredient?
- Succinylcholine chloride dihydrate.
- Who is the labeler?
- Baxter Healthcare Corporation, NDC labeler code 43066. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Succinylcholine Chloride?
- 31 other product NDCs are listed under this name. See all Succinylcholine Chloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Succinylcholine Chloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | REMEDYREPACK INC. | 70518-4409 | 70518-4409-00 |
| Succinylcholine Chloride | Succinylcholine chloride dihydrate 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Fresenius Kabi USA LLC | 65219-274 | 65219-0274-05 |
| Succinylcholine Chloride | Succinylcholine chloride dihydrate 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Fresenius Kabi USA LLC | 65219-276 | 65219-0276-10 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 82449-232 | 82449-0232-02 |
| Succinylcholine Chloride | Succinylcholine chloride dihydrate 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Baxter Healthcare Corporation | 43066-127 | 43066-0127-05 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Devatis, Inc. | 73043-021 | 73043-0021-01 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Eugia US LLC | 55150-315 | 55150-0315-25 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Somerset Therapeutics, LLC | 70069-783 | 70069-0783-1070069-0783-25 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Lifestar Pharma LLC | 70756-613 | 70756-0613-1070756-0613-25 |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Henry Schein, Inc. | 0404-9983 | 00404-9983-20 |
Other NDCs under ANDA 218878
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Succinylcholine Chloride | Succinylcholine chloride dihydrate 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | Baxter Healthcare Corporation | 43066-127 |